SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000899140-97-000732
Filing Date
1997-11-10
Accepted
1997-11-10 00:00:00
Documents
1
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G SC 13G/A 14478
  Complete submission text file 0000899140-97-000732.txt   16441
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02138 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47221 | Film No.: 97711800
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O WARBURG PINCUS & CO 466 LEXINGTON AVENUE 10TH FLOOR NEW YORK NY 10017-3147
Business Address 466 LEXINGTON AVENUE 10TH FLOOR C/O E M WARBURG PINCUS & CO NEW YORK NY 10017-3147 2128780600
WARBURG PINCUS CAPITAL CO LP (Filed by) CIK: 0000898600 (see all company filings)

IRS No.: 061183391 | State of Incorp.: DE | Fiscal Year End: 1231